carteolol has been researched along with Endophthalmitis in 1 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
Endophthalmitis: Suppurative inflammation of the tissues of the internal structures of the eye frequently associated with an infection.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scoville, B | 1 |
| Krieglstein, GK | 1 |
| Then, E | 1 |
| Yokoyama, S | 1 |
| Yokoyama, T | 1 |
1 trial available for carteolol and Endophthalmitis
| Article | Year |
|---|---|
Measuring drug-induced eye irritation: a simple new clinical assay.
Topics: Blood Pressure; Carteolol; Endophthalmitis; Humans; Male; Ophthalmic Solutions; Pulse; Time Factors; | 1985 |